Summary: Uncertainty and delay are common in the diagnosis of acute coronary syndromes (ACS). In the last 20 years, the need for faster, more accurate, and more cost-effective diagnosis gave rise to the concept of specialized treatment of patients with chest pain in emergency departments (EDs). The original strategy dedicated a separate section of the ED and a nursing staff to the task of rapid intervention in patients with acute myocardial infarction (MI) and triage of low-risk patients. Chest pain centers grew quickly in popularity but evolved with a variety of goals, staffing plans, diagnostic resources, and levels of commitment. Three existing centersthe University of Cincinnati Heart ER, Brigham and Women's Hospital, and the Medical College of Virginia-have implemented chest pain strategies with the common aims of (1) screening for the entire spectrum of coronary artery disease, (2) avoiding unnecessary admissions, and (3) using multiple diagnostic modalities. Yet, they differ in the specifics of their approaches and diagnostic methods (e.g., echocardiography vs. treadmill vs. myocardial perfusion imaging). The safety and cost effectiveness of these centers are discussed.
Introduction
The diagnosis of acute coronary syndromes (ACS) by conventional assessment in an emergency department (ED) has long been a source of uncertainty and error. More than 90 million patient visits to EDs occur in the United States annually, 1 of which an estimated 8 million are related to complaints of chest pain or an equivalent symptom complex that suggests potential or acute cardiac ischemia. 2 Erring on the side of caution, physicians have tended to overestimate the incidence of acute myocardial infarction (MI) in this population and admit a large number of patients to the coronary care unit (CCU); almost two thirds of patients with chest pain are admitted, but only 13 to 15% ultimately are ruled in for acute MI. On the other hand, traditional assessment has also resulted in a high rate of "missed" MIs: Of the 40% of patients with chest pain who are discharged from the ED, 1 to 5% actually have MI. [3] [4] [5] These diagnostic errors are costly in many ways. The rule-in process generates at least $600 million per year in unnecessary inpatient expenses. 5 Worse, patients whose MI is "missed" have a mortality rate of about 16% 5 ; their complications account for approximately 21% of malpractice awards against emergency physicians 6 even though patients with chest pain make up only 3 to 5% of a typical emergency physician's practice. Certainly the problem is not limited to emergency physicians: cardiologists also are vulnerable to misdiagnosis of MI when they see patients in their offices. Primary care physicians, internists, and family physicians account for about two thirds of missed MIs with adverse outcomes, largely because they collectively see large numbers of patients in the office, a phenomenon that will only worsen as a result of the national shift from specialty care to primary care.
Clinical, economical, and technological influences have converged in the last 2 decades to force change in acute MI care, and many EDs in the United States have explored ways to improve both the speed and accuracy of triage of patients with chest pain and reduce costs in the process. These have come to be known as "chest pain centers." The objective of the current paper is to describe the evolution of chest pain centers and focus on several innovative models that vary in both labeling and substance, not only among themselves but also from the original concept of chest pain centers.
dealing with patients with chest pain. The concept, known as the chest pain center strategy, 7-11 is still evolving today but is unquestionably popular: an estimated 700 to 1,000 chest pain centers are in place in the United States; growth has tended to double every 10 months. 8 In essence, the chest pain center is a system for treating the cardiac patient separately and differently from the general flow of adult emergencies by managing suspected cardiac patients in a subsection of (or addition to) the ED. 11 No single model is defined or regulated, so centers can and do vary in mission, staffing, size, physical arrangement, and diagnostic and invasive capabilities. The prototype chest pain center was established in 1981 by Dr. Raymond Bahr of St. Agnes Hospital in Baltimore, Maryland. It opened in a 6,000-square-foot addition to the ED, sharing physicians and registration staff with the ED but dedicating a nursing staff and the space itself to patients with chest pain regardless of the intensity of the patient load. 11, 12 Prior work in CCUs had highlighted the clinical importance of prodromal symptoms of acute MI-intermittent, "stuttering" chest pain that precedes prolonged chest pain and is believed to occur in 50% of patients presenting with acute MI. 7, 12 Based on the belief that intervention during the prodromal stage could stop an evolving infarction, the St. Agnes center was modeled to serve, in large measure, as a "damage control area" for rapid intervention and the conversion of patients with acute MI to "prodromal patients who have not yet had an MI." 7, 8 Beyond this role, the center focuses on triage and definitive rule-out of acute MI in low-risk patients and on educating patients and the community about cardiac risk factors, prevention, chest pain awareness, and the importance of early treatment. 7, 8 
Evolution of Chest Pain Centers
The chest pain center concept was eagerly embraced as the principles of thrombolytic therapy and myocardial salvage became clearer in the last 15 years. However, during the period of exponential growth of new centers, Bahr's original concept evolved into many variations. Common names that have been adopted include "chest pain emergency room," "chest pain emergency department," "chest pain evaluation unit," "chest pain attack unit," "heart emergency room," and "short-stay coronary care unit." While these labels today can represent a substantive, efficient unit with advanced technology for the evaluation of cardiac patients, they can also mean a barely specialized space that amounts to little more than a marketing effort on the part of the hospital. 13 Hospital marketing leaders learned about a decade ago that merely adding the label to a facility could greatly increase market share, and under a feefor-service reimbursement structure, the increase could mean a revenue windfall. That situation is changing now that capitation and managed care are factors in most communities. On the other hand, the potential for a well-run chest pain center to be a cost-effective "gatekeeper" for inpatient admissions is highly attractive in the managed care environment. 13 Among current models of chest pain centers, some focus strictly on the initial triage and treatment of patients with possible acute MI. Others provide comprehensive testing for acute MI and other coronary syndromes using short-term observation, serial electrocardiogram (ECG), and biochemical markers of myocardial injury [e.g., creatine kinase (CK)-MB or troponins]. If acute MI and unstable angina are ruled out, some units conduct treadmill or pharmacologic provocation of ischemia and assess risk by means of ECG, echocardiography, or radionuclide perfusion imaging. Centers are staffed by emergency physicians, internists, cardiologists (or cardiology fellows), or some combination of the above. Some centers provide a wide range of therapeutic alternatives for patients with acute MI, including direct percutaneous coronary intervention (PCI). Others offer only pharmacologic management (e.g., thrombolytic therapy, heparin, aspirin, beta blocker). Like the original St. Agnes model, many chest pain centers maintain extensive community outreach and public education. 9, 11, 14 Despite their intuitive appeal, chest pain centers as a group have not yet been proven cost effective or clinically superior to standard ED care of cardiac patients. A widely cited analysis by Shesser and Smith 11 suggests that, if adopted as a national strategy, chest pain centers would be strikingly inefficient. The authors estimated that an extra 1,029 lives per year would be saved (morbidity reductions were not analyzed) if chest pain centers were established in the country's 5,400 hospital-based EDs: approximately 39 lives would be saved by reducing sudden "lobby deaths," a little over 900 lives, by providing faster reperfusion, and approximately 89 lives by reducing "missed" heart attacks. The cost of realizing these benefits was estimated at $378 million to $3.78 billion, comprised of construction, staffing, equipment, and marketing costs. Therefore, the cost per life saved would total $378,000 to $3.78 million. Stressing that time to treatment remains the variable most critical to morbidity and mortality, the authors argue that unless chest pain centers accomplish treatment much faster than traditional EDs, they will not make a large difference in the effectiveness of care.
The Chest Pain Center in Practice
Nonetheless, prospective randomized data support the effectiveness of individual chest pain units when judged as alternatives to hospital admission of low-risk patients. Roberts et al. 15 found at Cook County (Illinois) Hospital that costs for chest pain patients randomized to accelerated diagnostic protocols (ADPs) in the ED averaged $1,528 per patient versus $2,095 per control patient randomized to immediate admission (p < 0.001). Length of stay for the ADP patients averaged 33.1 h versus 44.8 h for control patients (p < 0.01). These results emerged even though ADP patients turned out to have more severe disease and more diagnostic tests than controls even though the 45% of ADP patients who were ultimately hospitalized had higher per-patient costs than controls. 15, 16 Of importance is the fact that this study, like oth-ers, 17, 18 found no increased short-term risks for patients who were discharged after ED evaluation.
Most recently, the Chest Pain Evaluation in the Emergency Room (CHEER) investigators reported that treatment in an ED-based chest pain observation unit was safe, effective, and associated with a significant reduction in resource utilization over 6 months compared with regular hospital admission in an intermediate-risk Virginia population. 19 The study evaluated the outcomes of 424 patients and found a 45.8% reduction in the rate of hospital admission for patients with an intermediate risk of unstable angina and no increase in the rate of adverse events after a median stay in the chest pain observation unit of 9.2 h.
The remainder of this article will describe several existing models of chest pain centers that have evolved as variations on the original concept with uniquely effective attributes.
The University of Cincinnati Model: Chest Pain Evaluation Unit
In the early 1990s, a chest pain center concept began to emerge with a focus on the partnership between the ED and CCU to develop a more streamlined strategy involving cardiologists and emergency physicians. This concept of the chest pain evaluation unit (CPEU) was pioneered by Dr. Brian Gibler and colleagues at the University of Cincinnati. Known as the Heart ER, the distinguishing feature of the CPEU is that it augments the diagnostic capabilities of the ED itself. Although it functions as a specialized unit of the ED, the CPEU shares the ED nursing staff and can perform "fast-track" ruleout of acute MI in the ED 24 h a day, 7 days a week.
Patients with low to intermediate likelihood of unstable angina are eligible for the Heart ER fast-track protocol (patients at high risk or with a diagnostic ECG are treated and admitted) (Fig. 1) . They are first evaluated by serial CK-MB measurements and continuous 12-lead ECG with serial STsegment trend monitoring over 9 h. 10, 17 An alarm on the ECG monitor sounds if there is a persistent ST change of 1 mm. A cardiology fellow is in-house at all times, so that at the end of any 9-h period, if MI has been ruled out in a patient but risk factors are present, the decision can be made to obtain further tests to exclude the possibility of a fixed coronary artery lesion. The first choice is a rest echocardiogram; if it is negative, the cardiologist might order an exercise treadmill test, which is available at all times in the ED. Other test options include cardiac catheterization, stress echocardiography, and outpatient exercise (or pharmacologic) thallium imaging. Patients evaluated in the CPEU are treated and billed as outpatients.
Evidence supports the Heart ER as a safe and highly costeffective strategy for chest pain care. Gibler et al. 17 reported on outcomes of 1,010 consecutive patients evaluated at the center. Of this group, 829 (82%) were discharged from the ED; 153 (15%) were admitted to the hospital, where cardiac diagnoses were confirmed in 52 (5%); and 28 (2.8%) went home against medical advice before evaluation was completed. One-month mortality data showed five deaths in total, but only one was definitely due to ACS (in a patient admitted directly to the CCU from the CPEU). A cost analysis comparing the CPEU protocol with inpatient evaluation of patients hospitalized because the ER was full during the same time period found that inpatient evaluation was more than twice as expensive: $2,810 per inpatient versus $1,368 per CPEU patient. 20 The Brigham and Women's Model: Critical Pathway/Checklist
The chest pain protocol in the ED at Brigham and Women's Hospital in Boston, Massachusetts, uses a "critical pathway" approach to evaluation and treatment. Also known as clinical pathways or care paths, critical pathways identify the specific sequence and timing of the actions of physicians and nursing staff to achieve the desired outcomes for patients. 21 At Brigham and Women's, the chest pain pathway starts in the ED and carries on through the patient's evaluation and disposition, with "checklists" on the critical pathway flowsheets that allow monitoring and feedback of information to the providers about achievement of patient outcomes. This allows adjustments to be made as the patient progresses along the pathway. 22 The overall goal of the critical pathways program at Brigham and Women's is to reduce admission rates, lengths of stay, and adverse outcomes for patients with chest pain at low risk of ACS. 22 Patients whose ED evaluation indicates "possible ischemia" are first routed according to their ability to walk (Fig. 2) . Those who are able to walk are observed for 6 h and then either treadmill tested, if they are stable, or observed further. Those who cannot walk are observed for 12 h and then discharged if stable. Clinical outcomes and timing of patient progress along the pathways are closely tracked and recorded by the physicians and nurses.
In a retrospective analysis, Nichol et al. 22 applied eligibility criteria for the critical pathways to an existing cohort of patients with chest pain who presented to Brigham and Wom- en's ED in the early 1990s. The authors calculated the potential impact on safety and resource use if pathway-eligible patients who actually were admitted had instead been routed to a 6-or 12-h pathway. Of the 4,585-patient cohort, 2,898 (63%) were admitted; of these, 1,152 (40%) were judged to have been eligible for critical pathways; and of these, 1,068 (93%) had a benign clinical course during early hospitalization. Implementation of the critical pathway approach, therefore, would substantially but safely have affected resource use. By the authors' estimates, a 17% reduction in admissions and an 11% reduction in length of stay would occur, even if fewer than half the eligible patients had been discharged after observation and exercise testing on the pathway.
The Medical College of Virginia Model: Critical Pathways Track Approach
The Medical College of Virginia (MCV) in Richmond, Virginia, is an institution with an 890-bed teaching hospital, a 65-bed ED, and 24 emergency physicians. The ED treats more than 85,000 patients per year, including two thirds of the city's ambulance traffic. About 12 to 15 patients with chest pain present each day.
In 1994, MCV began a sophisticated approach to the triage and treatment of patients with chest pain in the ED. It is not termed a chest pain center but is a vertically integrated chest pain program with a track approach that starts in the prehospital care system, works its way through the critical pathways of the ED, CCU, or various diagnostic services, and ends by delivering the patient back into the hands of the primary care provider in the community. 14, 23 The approach has three major goals: (1) to rule out MI, (2) to rule out unstable angina, and (3) to screen (via next-day stress testing) for clinically significant coronary artery disease in patients believed to be at risk. If all of these clinical problems are ruled out, an additional goal is to identify noncardiac sources of chest pain through appropriate outpatient procedures. For example, if a stress test clears a patient of cardiac ischemia and the next most likely etiology is gastrointestinal, the patient can be referred for an immediate endoscopy that day.
Beginning in the field, multiple complementary technologies comprise the critical pathways at MCV. All of the city's ambulances have prehospital 12-lead ECG capability. Depending on the ECG results, paramedics will or will not administer nitrates or follow a thrombolytic therapy checklist, based on standing orders; they will then tell the ED whether the incoming patient is a likely candidate for thrombolytic therapy or may require immediate cardiac catheterization. The ED immediately assigns a bed for the patient and prepares a preregistration packet for later completion.
Once in the ED, patients with chest pain bypass registration and are brought directly into the treatment unit, part of the adult acute treatment area of the ED. A nurse assesses vital signs and obtains an ECG, which is then assessed by one of the attending emergency physicians (five to seven attendings are on duty 24 h a day). The physician reviews the ECG, takes a brief history, examines the patient, and makes an immediate triage decision, assigning the patient to one of five critical pathways, or tracks (Fig. 3) . Assignment is based on the probability of ACS and driven by specific interventional goals. 18, 23 Critical pathways: Track 1 patients, who have an obvious acute MI and ST-segment elevation, are treated promptly with thrombolytic therapy or direct PCI and admitted to the CCU for further care. Track 2 patients typically have prolonged or intermittent chest discomfort with ST-segment depression and/or T-wave inversions, suggesting a high probability of unstable angina or non-Q-wave infarction; these patients are treated with heparin, aspirin, intravenous nitroglycerin, and (when indicated) a glycoprotein IIb/IIIa receptor inhibitor and are admitted to the CCU for ECG monitoring and measurement of cardiac markers (CK-MB and troponin). At the other extreme are Track 5 patients, who have the lowest probability of ACS and are discharged after appropriate care. The typical patient in Track 5 is younger than age 30, has a normal ECG, no cocaine use or other cardiac risk factors, and, most important, an obvious noncardiac etiology of chest pain-for example, a basketball player who has been elbowed in the chest.
Less obvious cases are assigned to Track 3 or Track 4. These patients, who have intermittent chest discomfort and nondiagnostic ECGs, present the greatest diagnostic challenge in any ED. Track 3 patients are defined as having had at least one episode of discomfort suggesting probable unstable angina and lasting 20 to 30 min or more. These patients are fasttracked in a 9-h observation period in the CCU, with accelerated measurement of cardiac markers (myoglobin and CK-MB) and an immediate technetium ( 99m Tc) sestamibi rest study. If all tests are negative during the observation period, Track 3 patients undergo a 99m Tc sestamibi exercise study. If it is negative, they are discharged. Track 4 patients, considered to be atypical low-risk patients with possible unstable angina, are evaluated in the ED with a 99m Tc sestamibi rest study. If the study is negative, the patient is released but is scheduled for a 99m Tc sestamibi exercise study in the ED for the following day. Evaluation of the MCV strategy: At MCV, 99m Tc injection is available 24 h a day. Injection takes place as soon as possible after the patient arrives in the ED, and gated single-photon emission computed tomography (SPECT) imaging is performed within 60 to 90 min. Since the inception of MCV's critical pathway track protocol in 1994, over 10,000 99m Tc sestamibi studies have been performed in the ED. We have found a true false-positive rate based on coronary angiography in only 0.5% of Track 3 and 4 patients. Two thirds of acute MIs missed by ECG but detected by imaging have been posterior or lateral, where the ECG is most insensitive.
99m Tc sestamibi rest imaging has been successful in discriminating risk levels at MCV, 18, 24 a result that can be credited to SPECT and to careful and consistent interpretation of images. Tatum et al. analyzed outcomes of 1,187 patients at MCV who received immediate 99m Tc rest studies after track assignment. 18 Adverse cardiac outcomes were consistent with assignment, such that patients designated Track 1, 2, 3, and 4 had acute MI rates of 96, 13, 3, and 0.7%, respectively. Sensitivity for acute MI was 100% and specificity was 78%. At 1 year, the risk of acute MI, revascularization, or cardiac death was 42% in patients with abnormal images and 3% in those with normal images (relative risk 16.5; p < 0.0001). Despite such supportive findings, 99m Tc sestamibi is not necessarily superior to two-dimensional echocardiography at rapid risk assessment. Kontos et al. compared side-by-side echocardiograms and 99m Tc sestamibi images from 185 Track 3 and 4 chest pain patients at MCV and found the methods to be largely comparable in terms of sensitivity and specificity. 25 Quality improvement and community outreach: The MCV protocol is continuously reviewed and revised. A cardiology fellow leads weekly multidisciplinary continuous quality improvement (CQI) conferences where cases are reviewed. Emergency physicians have cardiac case reviews at least monthly. A Grand Rounds is dedicated each month to a caseby-case review to refresh ECG recognition skills and clarify the pathway process.
The MCV program has a full-time community outreach coordinator who communicates with the primary provider in Richmond. A system is in place that allows any physician in the community to refer patients directly from the office for 99m Tc sestamibi study 24 hours a day. Results are faxed back to the referring doctor. If the patient is discharged, the ED sends a letter to the doctor the next day, via the outreach coordinator, so that the patient can be followed appropriately.
Cost: Although more diagnostic testing is performed initially in the MCV approach, the number of pathway patients admitted to the hospital from the ED has decreased by about 20% compared with standard ED care. More patients with unstable angina but fewer with noncardiac chest pain have been admitted. Length of stay has decreased by 83% for noncardiac patients and is halved for unstable angina patients, resulting in savings in hospital charges 23 (Table II) . Overall, the critical pathway strategy is estimated to cost $300,000 for every 100 patients with chest pain evaluated, compared with an estimated $700,000 per patient evaluated in a standard ED strategy.
Conclusions
The picture emerging at the close of the twentieth century is one with no single, ideal approach to chest pain evaluation but rather an array of demonstrably or potentially effective approaches at individual institutions. The approaches described herein show how separate institutions can turn diagnostic tools and processes to their greatest advantage, tailoring a practical, safe, and cost-effective technique to evaluate patients who present to the ED with chest pain. It is likely that at any given moment at any given institution, any systematic and separate approach to patients with chest pain is better than the traditional ED strategy of ECG, physical exam, echocardiogram, and clinical judgment.
Nevertheless, the picture indicates that the most effective successful chest pain strategies should have several essential components. They should screen effectively for the entire spectrum of ACS-not just focus on the rule-out of acute MI but pursue equally the identification of cardiac ischemia, latent coronary artery disease, and risk factors. The most effective strategies should safely reduce unnecessary admissions and thereby rein in costs of care. They also should use multiple complementary diagnostic modalities, with the specific aim of detecting disease that might be overlooked with a more traditional approach. These modalities include 99m Tc myocardial perfusion imaging, two-dimensional echocardiography, and exercise treadmill testing, each of which is a mainstay of current chest pain evaluation protocols. Regardless of the strategy that is instituted, a quality improvement plan is another important part of the process.
It has been suggested that the true value of a chest pain center lies not in immediate dollar savings but in the institutional commitment to a high level of cardiac expertise, which inspires community confidence and economic well-being over time. 13 While this commitment is indispensable, there is already evidence that individual programs can be cost effective even in the near term. As the concept of chest pain centers evolves in the twenty-first century, the hope is that both economic and community benefits will grow hand in hand. 
